BD (Becton, Dickinson and Company)
BD is a global medical technology company that develops, manufactures, and sells a wide array of medical instruments, reagents, and systems. The company holds a market-leading position in the cell analysis market, particularly dominating the single-cell analysis segment with an estimated 22.8% market share. BD’s core contribution is through its innovative flow cytometry and genomic tools, which are indispensable for high-throughput studies in immunology, cancer research, genetic diseases, and chronic disorders. Key product innovations include the BD FACSDiscover A8 Cell Analyzer, which incorporates spectral and real-time cell imaging technologies, and the BD Rhapsody system, a genomic tool that supports high-throughput single-cell multiomics analysis without compromising sample integrity. Furthermore, BD is known for pioneering technologies such as BD CellView and BD SpectralFX, which significantly enhance flow cytometry capabilities. By providing comprehensive and advanced cellular analysis platforms, BD enables scientists to conduct sophisticated studies and accelerates discovery across the life sciences globally.
Latest Market Research Report on Cell Analysis Download PDF Brochure Now
Thermo Fisher Scientific
Thermo Fisher Scientific is a globally renowned leader providing a vast array of scientific solutions, instruments, reagents, and services for the life sciences and healthcare sectors. The company is a critical player in the cell analysis market, holding a significant 20.9% market share in the single-cell analysis segment. Thermo Fisher’s contribution is centered on its advanced technologies for single-cell genomics and proteomics, including the high-end analytical instruments and software platforms like Ion Torrent and Applied Biosystems. These systems are essential for researchers exploring cellular heterogeneity and disease mechanisms rapidly. The company is committed to developing integrated workflows, as evidenced by its partnership with CELLENION to combine single-cell isolation systems (like CELLENION’s CellenOne) with mass spectrometry-based proteomics analysis (using Thermo Fisher’s Orbitrap mass spectrometers). This strategy of offering end-to-end solutions, from sample isolation and preparation to high-end detection, cements Thermo Fisher’s position as a key provider of the necessary infrastructure and tools for drug discovery, diagnostics, and fundamental biological research globally.
Danaher Corporation (Beckman Coulter Life Sciences)
Danaher Corporation is a diversified global science and technology conglomerate whose significant presence in the cell analysis market is primarily driven by its Beckman Coulter Life Sciences division. Danaher holds a substantial 16.2% share in the single-cell analysis market. Beckman Coulter Life Sciences is a major manufacturer of scientific research instruments and reagents, specializing in fully-automated cellular analysis instruments for academic and pharmaceutical markets. A notable product is the Navios EX flow cytometer, which utilizes high-powered solid-state lasers and innovative scatter detection technology for flexible microparticle and cell analysis. Danaher is focused on delivering integrated and automated solutions for complex laboratory workflows. To enhance its offerings, the company’s Beckman Coulter Life Sciences division partnered with 10x Genomics to expand automation solutions for single-cell assay workflows, highlighting their commitment to streamlining high-throughput genomic and cellular research and providing the technological backbone for next-generation precision medicine.
Merck KGaA (MilliporeSigma)
Merck KGaA is a global science and technology company with a long history, and its life science business, MilliporeSigma, is a major contributor to the cell analysis market, holding a 6.4% market share in the single-cell analysis segment. Merck provides a comprehensive portfolio of innovative tools, technologies, reagents, and instruments for both single-cell analysis and proteomics. These solutions are critical for supporting cutting-edge research in oncology, genomics, and personalized medicine. MilliporeSigma supplies essential products such as biochemicals, reagents, and instruments for all phases of cellular analysis, including cell culture, separation, and high-resolution detection. Their expertise spans advanced reagents and instrumentation necessary for sophisticated techniques like single-cell RNA sequencing and proteomics. Through its extensive product line, Merck reinforces its role as a key global supplier, enabling complex cellular research and driving scientific advancements.
10x Genomics
10x Genomics is a dynamic life science technology company and a recognized pioneer in the single-cell analysis field, holding an influential 12.2% market share. The company provides innovative solutions that allow researchers to uncover cellular diversity and function at unprecedented resolution, fundamentally transforming genomics and biomedical research. Their flagship offering is the Chromium platform, which enables high-throughput single-cell RNA sequencing. This technology works by partitioning and barcoding individual cells or nuclei, which facilitates the concurrent analysis of thousands to millions of cells. This capability is essential for researchers studying cell-to-cell variability in complex biological systems, such as in cancer, immunology, and neurological diseases. By continually developing innovative instruments and consumables for single-cell analysis, 10x Genomics has established itself as a central player that is actively driving technological advancements and accelerating scientific discoveries in the genomic and cellular research landscape.
Sartorius AG
Sartorius AG is a globally operating manufacturer and supplier specializing in laboratory products and bioprocess solutions, making it a significant force in the cell analysis market. Headquartered in Germany, the company offers a range of instruments, consumables, and services critical for chemical, biopharmaceutical, and academic setups. Sartorius provides cutting-edge bioprocess and single-cell analysis tools, which are vital for research and development. An example of their innovation is the Sartorius CellCelector, a specialized instrument that supports the development of new diagnostics and therapies by enabling precise single-cell isolation and cell line development. The company is organized into bioprocess solutions and lab products and services divisions, both of which are dedicated to delivering robust instruments and systems that enhance the efficiency and accuracy of cell analysis, biomanufacturing processes, and overall cellular research.
Agilent Technologies, Inc.
Agilent Technologies, Inc. is a global leader in analytical instrumentation and laboratory systems, strategically integrating advanced microfluidics across its platforms to serve the cell analysis market. The company’s solutions are designed to meet the critical need for higher throughput, enhanced reproducibility, and precise sample handling in modern research. Agilent’s comprehensive offering includes specialized microfluidic chips, precision reagents, and consumables for various analytical assays. Their microfluidics technology is particularly influential in single-cell analysis and genomics, fields where precise control of minute fluid volumes is paramount. For instance, their Bioanalyzer Protein kits leverage microfluidic chips to perform high-quality sample analysis with significantly reduced complexity and time. By developing reliable, high-performance tools and supporting scientific advancements with its robust laboratory infrastructure, Agilent plays a pivotal role in empowering researchers in drug discovery, cancer research, and fundamental biological studies.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories is a preeminent global leader in the life sciences research and clinical diagnostics markets, distinguished by its strong contributions to the cell analysis industry, particularly through digital and droplet microfluidics. The company significantly expanded its presence in the single-cell analysis domain with the acquisition of Celsee, Inc., which specializes in single-cell isolation, detection, and analysis instruments and consumables. Bio-Rad’s offerings, such as the Celselect Slides 2.0, are microfluidics-based solutions specifically designed to enhance the capture and recovery of rare and circulating tumor cells (CTCs), which is critical for personalized cancer research. Additionally, their cutting-edge microfluidic systems are indispensable for high-throughput screening and complex genomic analysis. A major highlight is their droplet digital PCR (ddPCR) technology, a key tool that provides ultra-sensitive and absolute quantification of nucleic acids, frequently used in single-cell and molecular analysis, thereby accelerating advancements in precision medicine.
PerkinElmer (Revvity)
PerkinElmer, which has since been rebranded as Revvity, Inc., is a globally recognized corporation that develops and provides specialized solutions for the life sciences, diagnostics, and analytical instrumentation sectors, maintaining a significant role in the cell analysis market. The company’s expertise lies in creating platforms and systems engineered for the highly efficient manipulation of small-volume fluids, a capability that is crucial for modern scientific applications. Their technologies are instrumental in enabling vital processes within genomics, proteomics research, and sophisticated drug discovery programs. For example, the company has engaged in strategic partnerships, such as with Honeycomb Biotechnologies, to launch the HIVE scRNAseq Solution for single-cell RNA sequencing. By leveraging the benefits of miniaturization and offering robust, specialized microfluidic instruments and consumables, Revvity helps researchers and clinicians streamline complex laboratory workflows, reinforcing its reputation as a key market player driving technological breakthroughs.
QIAGEN N.V.
QIAGEN N.V. is a leading global provider of sample and assay technologies, making its products fundamental to molecular diagnostics, applied testing, and academic research within the cell analysis market. The company is crucial for researchers by offering solutions that span the entire workflow of cellular and molecular analysis, from high-quality sample preparation to detection. QIAGEN’s single-cell genomics solutions, such as their specialized QIAseq kits, are essential for enabling researchers to efficiently isolate, stabilize, and analyze cellular components, including DNA and RNA. These products are indispensable for conducting complex cellular studies, such as single-cell RNA sequencing, which is vital for understanding cellular diversity and function in complex biological systems. QIAGEN’s focus on providing integrated and high-performance solutions ensures it supports the development of new diagnostics and accelerates advancements in cellular biology research globally.
Latest Market Research Report on Cell Analysis Download PDF Brochure Now